GB1282912A - Polyvalent vaccines for immunization against local gastro-intestinal infections - Google Patents

Polyvalent vaccines for immunization against local gastro-intestinal infections

Info

Publication number
GB1282912A
GB1282912A GB39983/69A GB3998369A GB1282912A GB 1282912 A GB1282912 A GB 1282912A GB 39983/69 A GB39983/69 A GB 39983/69A GB 3998369 A GB3998369 A GB 3998369A GB 1282912 A GB1282912 A GB 1282912A
Authority
GB
United Kingdom
Prior art keywords
deactivated
pathogens
gastro
polyvalent vaccines
polyvalent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB39983/69A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1282912A publication Critical patent/GB1282912A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

1282912 Polyvalent vaccines for immunization against local gastro-intestinal infections SCHERING AG 11 Aug 1969 [10 Aug 1968] 39983/69 Heading A5B Polyvalent vaccines suitable for oral administration comprising deactivated pathogens of at least two different genera, each of the deactivated pathogens being capable of providing immunity against a local gastrointestinal infection, may be prepared by mixing the pathogens together either before or after their deactivation. The deactivated pathogens may be deactivated Salmonellae, Shigellae and/or dyspepsia - Coli bacteria. Pharmaceutical preparations comprise the polyvalent vaccine in admixture or conjunction with a carrier suitable for oral administration and may be in the form of capsules, tablets, pastilles, suspensions in a physiologically tolerable solution and foodstuffs.
GB39983/69A 1968-08-10 1969-08-11 Polyvalent vaccines for immunization against local gastro-intestinal infections Expired GB1282912A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1792256A DE1792256C3 (en) 1968-08-10 1968-08-10 Orally administered, polyvalent vaccines against local intestinal infections

Publications (1)

Publication Number Publication Date
GB1282912A true GB1282912A (en) 1972-07-26

Family

ID=5707335

Family Applications (1)

Application Number Title Priority Date Filing Date
GB39983/69A Expired GB1282912A (en) 1968-08-10 1969-08-11 Polyvalent vaccines for immunization against local gastro-intestinal infections

Country Status (11)

Country Link
US (1) US3651214A (en)
JP (1) JPS4819931B1 (en)
AT (1) AT295737B (en)
BE (1) BE737281A (en)
BR (1) BR6911415D0 (en)
DE (1) DE1792256C3 (en)
ES (1) ES370327A1 (en)
FR (1) FR2015423A1 (en)
GB (1) GB1282912A (en)
IL (1) IL32723A (en)
NL (1) NL163426C (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336015A (en) * 1970-06-03 1973-11-07 Unilever Ltd Rearing pigs
US4057627A (en) * 1972-03-21 1977-11-08 Helmut Anton Stickl Acne preparation for oral administration
US4328209A (en) * 1979-04-11 1982-05-04 Board Of Regents, The University Of Texas System Cholera vaccine
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
IT1199301B (en) * 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan BACTERIAL ANTIGENIC LYSATE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
MY128159A (en) * 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
WO2005086669A2 (en) * 2004-03-02 2005-09-22 University Of Georgia Research Foundation, Inc. Hydrogenase deficient bacterial strains

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3139382A (en) * 1961-10-31 1964-06-30 American Home Prod Bacterins and process of producing the same

Also Published As

Publication number Publication date
AT295737B (en) 1972-01-10
BE737281A (en) 1970-02-09
IL32723A0 (en) 1969-09-25
IL32723A (en) 1972-11-28
DE1792256A1 (en) 1971-11-04
BR6911415D0 (en) 1973-04-12
DE1792256B2 (en) 1978-11-09
US3651214A (en) 1972-03-21
FR2015423A1 (en) 1970-04-24
NL163426C (en) 1980-09-15
DE1792256C3 (en) 1979-07-05
ES370327A1 (en) 1971-08-01
NL163426B (en) 1980-04-15
JPS4819931B1 (en) 1973-06-18
NL6912159A (en) 1970-02-12

Similar Documents

Publication Publication Date Title
Raoult et al. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii
PH11870A (en) 14-desoxy-14-(substituted acetoxy)mutilins,their pharmaceutical compositions and method inhibiting bacterial infection
EP0024493A3 (en) Pneumococcal capsular polysaccharide, preparation thereof, multivalent pneumococcal vaccine and method of inducing active immunity
GB1282912A (en) Polyvalent vaccines for immunization against local gastro-intestinal infections
RU93053899A (en) METHOD FOR PRODUCING A VACCINE COMPOSITION, METHOD FOR PREVENTING INTESTINAL INFECTIONS
NO307867B1 (en) Method of preparation of a vaccine preparation for intestinal infection in humans caused by enterotoxigenic E. coli bacteria
MOOSA et al. Once daily ceftriaxone vs. chloramphenicol for treatment of typhoid fever in children
IL41902A0 (en) Novel immunogenic substance,its production,vaccine preparations containing it and their preparation
CA983851A (en) Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same
CA980251A (en) Adjuvants for vaccines and vaccine preparations containing them
Geddes et al. Chloramphenicol resistance in the typhoid bacillus.
CA943128A (en) Penicillins, their preparation and their pharmaceutical use
US3885011A (en) Vaccine adjuvants
GB680788A (en) Pharmaceutical products
PH10188A (en) 6-(l-3-acylamidoacetamido)-penicillanic acids,their pharmaceutically acceptable salts and their medicinal uses
FR2017318A1 (en) Orally administered pharmaceutical composition - containing an acrylic polymer
Lawrenson et al. Fatal infection caused by a multiply resistant type 3 pneumococcus
GB1212886A (en) Equine vaccine and vaccination treatment
Fox et al. Streptococcal M protein vaccines, rheumatic fever and human histocompatibility antigens
Schaad Chemoprophylaxis of bacterial meningitis
IL31437A0 (en) Novel methylergolene and methyl-ergoline derivatives,their preparation and pharmaceutical preparations containing them
Felber et al. Haemophilus influenzae Infections
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
NL175419C (en) METHOD FOR PREPARING OR MANUFACTURING ANTIBIOTIC ACTIVE PHARMACEUTICAL PREPARATIONS AND METHOD FOR PREPARING ANTIBIOTIC ACTIVE ALPHA-SUBSTITUTED 6- (ALFA- (3-ACYLUREIDO) -PETYL-ACIDYL-ACIDYL-ACIDYL)
SU100456A1 (en) Leptospirazna vaccine

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLE Entries relating assignments, transmissions, licences in the register of patents
PCNP Patent ceased through non-payment of renewal fee